baber/WOPTO huggingface dataset:
Patent AU-2016203532-B2 (AU)
Title: Parallel runtime execution on multiple processors
Inventor: MUNSHI AAFTAB
IPC: G06F9/50
Filed: 2016-05-27
Granted: 2018-01-18
Abstract: A method and an apparatus that schedule a plurality of executables in a schedule queue for execution in one or more physical compute devices such as CPUs or GPUs concurrently are described. One or more executables are compiled online from a source having an existing executable for a type of physical compute devices different from the one or more physical compute devices. Dependency relations among elements corresponding to scheduled executables are determined to select an executable to be executed by a plurality of threads concurrently in more than one of the physical compute devices. A thread initialized for executing an executable in a GPU of the physical compute devices are initialized for execution in another CPU of the physical compute devices if the GPU is busy with graphics processing threads. Sources and existing executables for an API function are stored in an API library to execute a plurality of executables in a plurality of physical compute devices, including the existing executables and online compiled executables from the sources.
Patent AU-2016206241-B2 (AU)
Title: Method for the elimination of mercury from a feedstock downstream of a fractionation unit
Inventor: GUILLOU FLORENT
IPC: C10G25/00
Filed: 2016-07-19
Granted: 2022-03-10
Abstract: METHOD FOR THE ELIMINATION OF MERCURY FROM A FEEDSTOCK 
DOWNSTREAM OF A FRACTIONATION UNIT 
******* 
10 
ABSTRACT 
Process for the elimination of mercury contained in a heavy hydrocarbon-containing 
15 feedstock downstream of a main fractionation unit, a process in which: 
a) the non-elemental mercury contained in the compounds of said feedstock is 
transformed to elemental mercury; 
b) a fractionation of said hydrocarbon-containing feedstock is carried out in a 
fractionation unit in order to produce a top effluent comprising elemental mercury; 
20 c) the top effluent obtained in stage b) is brought into contact with a mercury capture 
material contained in a unit for the capture of mercury, in order to obtain an effluent that 
is at least partially de-mercurized.  
No figure to be published 
7986420_1 (GHMatters) P103513.AU
Patent AU-2016206582-B2 (AU)
Title: Method of controlling a rate at which an upstream process feeds a conditioned product to a downstream process
Inventor: PETRI KENNETH C
IPC: G01G13/24
Filed: 2016-01-15
Granted: 2020-09-24
Abstract: A method of controlling an upstream and a downstream process wherein the upstream process conditions a stream of product delivered to the downstream process is provided. The control method uses an empirically determined formula to determine a metric for adjusting the activity of the upstream process to thereby adjust the rate with which the upstream process conditions and feeds a stream of conditioned product to the downstream process. The empirically determined formula determines the metric using two input variables: a duty cycle setting of the upstream process and an output rate of the downstream process expressed as a decimal amount of the output rate set-point.
Patent AU-2016210926-B2 (AU)
Title: Random-access response with analog beamforming
Inventor: FURUSKOG JOHAN
IPC: H04W74/08
Filed: 2016-01-21
Granted: 2018-08-16
Abstract: A system (66) and method (83, 90) of Random-Access Response, RAR, messaging when a base station (72) employs narrow beamforming. Multiple RAR messages are successively transmitted from the base station to a User Equipment, UE, (68) before any response to a RAR message is received from the UE. Thus, despite any calibration mismatch between Uplink, UL, and Downlink, DL, beams in the beamformed system, a RAR message is not only received by the UE, but is received over the most- suitable DL beam for that UE. Each RAR message may contain a message-specific scheduling-delay indicator in the UL grant carried in the RAR message to provide an adjustable time delay for the UE's uplink transmission scheduled by the UL grant. Multiple RAR transmissions can schedule a single UL transmission at a specific time instance or different UL transmissions at different time intervals. The UE may report to the base station the best DL RAR transmission detected by the UE.
Patent AU-2016254507-B2 (AU)
Title: Wound dressing
Inventor: HOGGARTH ANDREW
IPC: A61F13/02
Filed: 2016-04-27
Granted: 2020-02-20
Abstract: The present invention relates to a wound dressing composition for use as or in a wound dressing and to methods of making the wound dressing composition. The wound dressing composition comprises wicking material, and superabsorbent material that is punched into the wicking material. The action of punching the superabsorbent material into the wicking material acts to significantly increase the rate of absorption of the combination materials.
Patent AU-2016297671-B2 (AU)
Title: Method and system for pipeline condition analysis
Inventor: GONG JINZHE
IPC: G01L11/00
Filed: 2016-07-15
Granted: 2021-05-06
Abstract: A method and system for assessing the condition of a pipeline in a pipeline system is disclosed. The method includes generating a pressure wave in the fluid being carried along the pipeline system at a generation location along the pipeline system, detecting a first pressure wave interaction signal at a first measurement location along the pipeline system resulting from an interaction of the pressure wave with localised variations in the pipeline and then detecting synchronously a second pressure wave interaction signal at a second measurement location along the pipeline system resulting from the interaction of the pressure wave with localised variations in the pipeline. The method then involves comparing the first and second pressure wave interaction signals to determine a location of individual features in the first and second pressure wave interaction signals with respect to the generation location, the individual features corresponding to pressure wave reflections from localised variations in the pipeline and characterising the individual features to assess the condition of the pipeline.
Patent AU-2016305299-B2 (AU)
Title: DPEP-1 binding compositions and methods of use
Inventor: ROBBINS STEPHEN MARK
IPC: C07F9/30
Filed: 2016-08-11
Granted: 2021-03-11
Abstract: Pharmaceutical compositions and methods of their use are provided for reducing inflammation in a subject, blocking leukocyte recruitment, inhibiting tumor metastasis, treating sepsis and preventing/reducing acute kidney injury.
Patent AU-2016346886-B2 (AU)
Title: Pinch clamp device
Inventor: BURKHOLZ JONATHAN KARL
IPC: A61M39/28
Filed: 2016-10-06
Granted: 2019-10-31
Abstract: Pinch-style clamps can be designed for use in clamping or occluding plastic tubing, such as intravenous tubing. These pinch clamps can include a soft, polymer material applied to various surfaces of the pinch clamp to prevent abrasion or irritation to the patient, increase friction between the pinch clamp and the user operating said pinch clamp, increase friction between engaged surfaces of the pinch clamp to prevent premature or unintended disengagement of the clamp, or increase friction between the outer surfaces of the tubing and the clamping surfaces of the clamp. Various features or components can be employed to prevent lateral disengagement of the pinch clamp. A pinch clamp may also be configured with rounded outer edges to enhance patient comfort.
Patent AU-2016353534-B2 (AU)
Title: Modular transportation and storage system
Inventor: LANG ROBERT JAMES
IPC: B60P1/64
Filed: 2016-11-04
Granted: 2020-12-17
Abstract: The present invention relates to an improved truck and tray assembly and system for storing and transporting light weight building material such as timber and hardware.
Patent AU-2016364597-B2 (AU)
Title: Method for producing botulinum toxin
Inventor: KIM KYOUNG-YUN
IPC: C07K1/36
Filed: 2016-11-23
Granted: 2019-01-17
Abstract: The present invention relates to a method for producing a botulinum toxin comprising :(a) treating a culture of a botulinum toxin-producing strain with acid to form a botulinum toxin-containing precipitate; (b) adding a buffer to the botulinum toxin-containing precipitate of step (a), followed by clarification by at least one method selected from the group consisting of depth filtration (DF), microfiltration (MF), ultrafiltration (UF), sterile filtration, membrane chromatography (MC) and centrifugation; (c) subjecting the botulinum toxin-containing solution of step (b) to UF diafiltration, ammonium sulfate precipitation or hydrochloric acid precipitation, and then diluting a retentate resulting from the UF diafiltration in a buffer or dissolving a precipitate resulting from the ammonium sulfate precipitation or hydrochloric acid precipitate in a buffer; and (d) subjecting the retentate dilution, ammonium sulfate precipitate solution or hydrochloric acid precipitate solution of step (c) to anion-exchange chromatography (AEX) to purify the botulinum toxin.
Patent AU-2016366279-B2 (AU)
Title: Gypsum composition for dry-curing coating material, gypsum-based coating material, and construction method for gypsum-based coating material
Inventor: YOKOYAMA ITARU
IPC: E04F13/02
Filed: 2016-12-07
Granted: 2019-01-17
Abstract: Provided is a gypsum composition for a dry-curing coating material capable of forming a coating film in which color unevenness is suppressed while being thin and smooth when made to be a gypsum-based coating material by adding water. This gypsum composition for a dry-curing coating material contains a hemihydrate gypsum with an average particle diameter of no more than 50 μm, calcium carbonate with an average particle diameter of no more than 50 μm, and a setting retarder, the calcium carbonate content being 10-400 parts by mass and the setting retarder content being at least 0.1 parts by mass per 100 parts by mass of the hemihydrate gypsum.
Patent AU-2017201128-B2 (AU)
Title: Collectors for mineral flotation
Inventor: COUNTER JAMES ADRIAN
IPC: B03D1/00
Filed: 2017-02-20
Granted: 2018-04-12
Abstract: Abstract The invention provides methods and compositions for improving a froth flotation type separation. The method uses a microemulsion to improve the effectiveness of a collector. The improvement allows for low dosages of collector to work as well as much greater amounts of non-microemulsified collector.
Patent AU-2017203180-B2 (AU)
Title: Constructs for expressing transgenes using regulatory elements from Brachypodium ubiquitin genes
Inventor: KUMAR SANDEEP
IPC: C12N15/82
Filed: 2017-05-12
Granted: 2019-06-20
Abstract: Provided are constructs and methods for expressing a transgene in plant cells and/or plant tissues using the regulatory elements, including the promoters and/or 3'-UTRs, isolated from Brachypodium distachyon ubiquitin genes.
Patent AU-2017232120-B2 (AU)
Title: Attachment tether for a child safety seat
Inventor: CARPENTER JASON A
IPC: B60N2/42
Filed: 2017-09-21
Granted: 2019-11-07
Abstract: A child safety seat system can include a seat base positioned along a vehicle seat and a child seat that can be coupled and decoupled from the base. The system can include a base anchor system that is movably coupled to the base and that holds the base in place along the vehicle seat. The base can include a lock-off device to prevent the base anchor system from being removed or decoupled from the base. The child safety seat system can also include a restraining tether system that includes a looped tether portion and a seat attachment strap. The seat attachment strap can be removably coupled to the vehicle and the looped tether portion can be removably coupled to the child seat. A restraint attachment tether can be coupled to the restraining tether system and movably coupled to the base anchor system to prevent the restraining tether system from being separated from the base. 9507327_1 (GHMatters) P106932.AU 120 135 185
Patent AU-2017269197-B2 (AU)
Title: Multi-ply retractor/stabilizer and wound exposure device and method of use
Inventor: GALBIERZ THOMAS R
IPC: A61B17/02
Filed: 2017-05-19
Granted: 2021-10-21
Abstract: A multi-ply adhesive retraction device is provided which comprises a top layer, a backing layer and a stretchable middle layer between the top and backing layers. A middle-ply adhesive applied to substantially the entirety of the middle layer bottom surface to removably adhere the backing layer to the middle layer bottom surface. The device includes at least one bottom ply tab integral with the device which is operable to remove at least a portion of the backing layer from the middle layer to expose the adhesive of the middle layer. Additionally, the device includes at least one top ply tab which is operable to remove the top layer from the middle layer. The device can be applied pre-operatively, and then the top layer can be removed post-operatively to remain in place during healing of, for example, an incision site.
Patent AU-2017294643-B2 (AU)
Title: Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
Inventor: SULEIMAN OSAMA
IPC: C07D231/38
Filed: 2017-07-13
Granted: 2021-02-25
Abstract: This invention relates to a process for the preparation of Form A of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide. Also disclosed herein is Form A of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4- methylbenzamide, or pharmaceutical compositions thereof, obtainable by the process described herein.
Patent AU-2017323654-B2 (AU)
Title: Biological control of plant pathogenic microorganisms
Inventor: ELMER PHILIP
IPC: C12R1/645
Filed: 2017-09-11
Granted: 2023-05-25
Abstract: The present invention relates to the use of an isolated
Patent AU-2017340027-B2 (AU)
Title: Valve assembly
Inventor: KNIGHT GLENN WALTER
IPC: E03F7/02
Filed: 2017-10-03
Granted: 2023-03-16
Abstract: A valve assembly including a valve housing having an inlet, an outlet and an opening, and an insert removably insertable in the opening, the insert having a first side facing upwards and a second side facing downwards when positioned in the opening, the first side and the second side have a conduit positioned therebetween, and a control valve located at least partially within the conduit and movable between an open position and a closed position, the control valve in the closed position stops fluid from passing through the conduit, wherein when the insert is inserted in the opening and the control valve is in the closed position, the insert substantially seals the inlet and stops fluid flowing to the outlet.
Patent AU-2017408431-B2 (AU)
Title: Systems and methods for dynamic control of enteral feeding according to energy expenditure
Inventor: ELIA LIRON
IPC: G16H40/63
Filed: 2017-11-21
Granted: 2023-08-31
Abstract: A computer-implemented method of adjusting enteral feeding of a patient by an enteral feeding controller, comprising: computing an estimate of energy expenditure of the patient based on oxygen measurements and carbon dioxide measurements of the patient, computing a target composition and target feeding rate for the enteral feeding according to the computed estimate of energy expenditure, when the target composition and target feeding rate differ from a current enteral feeding composition and feeding rate by a requirement, generating instructions for adjustment, by an enteral feeding controller, of the rate of delivery of the enteral feeding according to the target composition, wherein the receiving the oxygen measurement, receiving the carbon dioxide measurement, and computing the estimate of energy expenditure are performing iteratively for every first time interval, and the generating instructions for adjustment are performed for a second time interval that is larger than the first time interval.
Patent AU-2018204490-B2 (AU)
Title: Concrete tile and molding material for same
Inventor: IMAGAWA AKIRA
IPC: B28B11/16
Filed: 2018-06-21
Granted: 2018-12-06
Abstract: A concrete tile comprising a tile body, the tile body having an upper face hardened through non-mold shaping, a lower face hardened through mold shaping, and a side surface that 5 comprises a cut end face in at least one side of the tile body, wherein the tile body contains alkali-resistant fibers in an entire thickness thereof in a state that the alkali-resistant fibers form fiber-containing granular bodies each having a circle equivalent diameter of less than 10 mm; the alkali-resistant fibers comprise at least one member selected from 10 the group consisting of polyvinyl alcohol-based fibers, polyethylene fibers, polypropylene fibers, acrylic fibers, and aramid fibers; and a flexural strength of a tile body cut piece of 30 mm x 150 mm of the concrete tile is not less than 6 N/mm2
Patent AU-2018281935-B2 (AU)
Title: Pre-warped rotors for control of magnet-stator gap in axial flux machines
Inventor: MILHEIM GEORGE HARDER
IPC: H02K1/27
Filed: 2018-05-25
Granted: 2022-04-28
Abstract: An assembly for use in an axial flux motor or generator includes a rotor plate and a magnet, the magnet having a surface that is orthogonal to a magnetization direction of the magnet. The rotor plate is adapted to engage a rotor shaft that rotates about an axis of rotation, and the magnet is attached to the rotor plate. The rotor plate and magnet are configured and arranged such that, if the rotor plate and the magnet are separated from all other magnetic field generating components, then a distance between a first plane that intercepts a first point on the surface and to which the axis of rotation is normal and a second plane that intercepts a second point on the surface and to winch the axis of rotation is normal is substantially greater than zero.
Patent AU-2018285412-B2 (AU)
Title: Cyclic peptides for protection against respiratory syncytial virus
Inventor: GHASPARIAN ARIN
IPC: A61K38/16
Filed: 2018-06-13
Granted: 2022-06-23
Abstract: The present invention relates to a cyclic peptide, a conjugate comprising said cyclic peptide and a lipopeptide building block, a bundle of said conjugates, a synthetic virus-like particle comprising at least one bundle of conjugates and pharmaceutical compositions comprising the same. The present invention further relates to said cyclic peptide, said conjugate said bundle of conjugates, said synthetic virus-like particle and said pharmaceutical compositions for use as a medicament, preferably for use in a method for preventing of an infectious disease or reducing the risk of an infectious disease, more preferably for use in a method for preventing or reducing the risk of an infectious disease associated with or caused by a respiratory syncytial virus. In particular, the present invention relates to a cyclic peptide, wherein said cyclic peptide comprises an amino acid sequence (I), wherein said amino acid sequence (I) comprises the following amino acid sequence: X1-X2-X3-C4-X5-X6-X7-C8-X9-X10-X11-P12-I13-T14-N15-D16-Q17-K18-K19-L20-C21- X22-X23-X24-C25-X26-X27-X28-X29-X30 (SEQ ID NO: 1), wherein X1, X2, X3, X5, X6, X7, X9, X10, X11, X22, X23, X24, X26, X27, X28 and X29 are independently of each other an amino acid; C4, C8, C21 and C25 are independently of each other cysteine; P12 is proline; I13 is isoleucine; T14 is threonine; N15 is asparagine; D16 is aspartic acid; Q17 is glutamine; K18 and K19 are independently of each other lysine; L20 is leucine; and X30 is an amino acid or a deletion, wherein said cysteines C4 and C25 form a first disulfide bond and said cysteines C8 and C21 form a second disulfide bond.
Patent AU-2018286629-B2 (AU)
Title: Identifiable ore sample tray and tracing method
Inventor: KEVIN DORMER
IPC: G06K7/10
Filed: 2018-12-31
Granted: 2019-11-14
Abstract: The invention relates to the secure tracking of ore sample trays such as core or chip trays to identify the ore sample held therein and provides for the incorporation of an electronically readable tag into a cavity formed within the structure of the tray behind a wall defining the sample receptacle. The tag may be built into the structure during manufacture or be retrofitted and then sealed into the cavity against tampering.
Patent AU-2018302191-B2 (AU)
Title: Method and system incorporating beam shaping optics and beam stabilization
Inventor: EVANS KENNETH MICHAEL
IPC: G01N15/10
Filed: 2018-07-19
Granted: 2021-05-13
Abstract: This disclosure pertains to analytical instruments and related methods incorporating beam shaping optics for differentiating very bright and closely related signals over a wide range of operating conditions with an improved and uniform performance.
Patent AU-2018304331-B2 (AU)
Title: Systems and methods for determining an order accepting mode for a user
Inventor: MA NING
IPC: G06Q10/06
Filed: 2018-06-27
Granted: 2021-05-06
Abstract: Systems and methods for determining an order accepting mode for a target service provider are provided. A method includes receiving a request for determining an order accepting mode for the target service provider. The method also includes obtaining an order accepting evaluation parameter with respect to the target service provider in response to the request. The method also includes determining an order accepting mode for the target service providers based on the order accepting evaluation parameter. The order accepting mode includes at least one of an order designating mode, an order striving mode, or an order quick-accepting mode.
Patent AU-2018315053-B2 (AU)
Title: Carbohydrate sensors
Inventor: CARON KARINE
IPC: C12N15/62
Filed: 2018-08-07
Granted: 2022-04-28
Abstract: The present invention relates to sensors and methods for detecting carbohydrates, such as lactose, in a sample. The sensors and methods may also be used to determine the amount of carbohydrate in the sample.
Patent AU-2018363086-B2 (AU)
Title: Tag for a teabag
Inventor: KING ALEXANDRA MARY
IPC: B65D85/812
Filed: 2018-10-22
Granted: 2021-09-16
Abstract: The invention relates to a tag to secure a string of a tea bag to a handle of a teapot, the tag being flexible and resilient_and comprising at least two adjacent areas separated by a cut that are partially separable from the tag.
Patent AU-2018363479-B2 (AU)
Title: Fusion proteins containing CD47 antibodies and cytokines
Inventor: WANG ZHENGYI
IPC: C07K14/705
Filed: 2018-11-12
Granted: 2021-09-16
Abstract: Provided are fusion proteins containing cytokines and novel CD47 antibodies or immunologically active fragments thereof, as well as pharmaceutical composition containing such fusion proteins that can be used for treatment of diseases mediated by CD47 or inhibition of phagocytosis or platelet aggregation. These fused proteins have low immunogenicity in humans and cause low or no level of red blood cell depletion or hemagglutination.